hope4today's activity feed Return to hope4today's profile
- December 15th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Princeton Scientists Find Way To Catalog All That Goes Wrong In A Cancer Cell
A team of Princeton University scientists has produced a systematic listing of the ways a particular cancerous cell has “gone wrong,” giving researchers a powerful tool that eventually cou…
- December 11th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Making A Difference: L’Oréal Paris Honors Women of Worth at Special Ceremony in New York City
L’Oréal Paris Honors Women of Worth at Special Ceremony in New York City. Ten Women Recognized for Making a Difference in their Communities with Special Guests including Mary J. Blige, Holly Ro…
- December 8th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
MAGP2 Gene Expression Signature: A Potential Ovarian Cancer Personalized Treatment Target
A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the December 8 issue of Cancer Cell, the research team describes fin…
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
OU’s Non-Toxic Drug Makes Ovarian Cancer Cells Respond To New Treatment & Undergo Cell Suicide
“Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SH…
- December 7th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
MIT Develops New Platinum Compound As Powerful As Cisplatin But Better Able To Destroy Tumor Cells
MIT chemists have developed a new platinum compound that is as powerful as the commonly used anticancer drug cisplatin but better able to destroy tumor cells. Massachusetts Institute of Technology c…
- November 22nd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“Too Often We Underestimate The Power Of A Touch”*
One of the most comforting forms of support you can give a person with cancer is the use of touch. Family caregivers can significantly reduce symptoms in cancer patients at home through use of simple…
- November 20th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
PI3K Pathway: A Potential Ovarian Cancer Therapeutic Target?
…[T]here are several PI3K signaling pathway targeting drugs in clinical development for use against ovarian cancer and solid tumors, including GDC-0941, BEZ235, SF1126, XL-147, XL-765, BGT226, a…
- November 14th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
“Decisions Are Made By Those Who Show Up”*
Responding to a threat of a funding reduction to the Department of Defense’s Ovarian Cancer Research Program, during the last week of October the Ovarian Cancer National Alliance urged advocates to…
- November 12th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Nationwide Registry to “Match” Study Volunteers With Researchers
Individuals who want to participate in research studies can connect online with researchers nationwide through the first disease-neutral, volunteer recruitment registry. ResearchMatch.org is a not-f…
- November 11th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
UCLA Researchers Significantly Inhibit Growth of Ovarian Cancer Cell Lines With FDA-Approved Leukemia Drug Dasatinib (Sprycel®)
The drug dasatinib (Sprycel®), approved for use by the U.S. Food and Drug Administration in patients with specific types of leukemia, significantly inhibited the growth and invasiveness of ovarian ca…
- November 4th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Æterna Zentaris’ LHRH-Receptor Targeted Therapy AEZS-108 Produces Positive Preliminary Results in Advanced Stage Ovarian Cancer
Preliminary Phase II clinical study evaluation shows that primary efficacy endpoint has been met for patients with advanced-stage, platinum-resistant, taxane-pretreated ovarian cancer who were treated…
- November 1st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Unusual Metals May Forge New Ovarian & Colon Cancer Drugs
Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the…
- October 23rd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
U.S. Ovarian Cancer Research Funding Slashed In Half — Take Action & Call Your U.S. Congressman & Senators Today!
As a result of a recent U.S. Senate mark-up, the funding for the Department of Defense Ovarian Cancer Research Program (DOD OCRP) has been slashed in half from $20 million to $10 million. Research co…
- October 22nd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Endocyte’s EC145 Produces Significant Anti-Tumor Activity In Advanced Stage Chemoresistant Ovarian Cancer Patients
Endocyte, Inc., … presented data from a Phase 2a clinical trial for EC145, … In 49 women with advanced-stage ovarian cancer, EC145 was shown to have anti-tumor activity in a significant p…
- September 24th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Modified Chemo Regime Increases Survival In Advanced Ovarian Cancer Patients But Adds Toxicity
Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination, Japanese researchers reported last week…
- September 15th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
FDA Clears Vermillion’s “OVA1″ Test To Determine Likelihood of Ovarian Cancer In Women With Pelvic Mass
The U.S. Food and Drug Administration cleared a test that can help detect ovarian cancer in a pelvic mass that is already known to require surgery. The test, called OVA1, helps patients and health car…
- September 1st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Barack Obama Proclaims September 2009 As National Ovarian Cancer Awareness Month
Yesterday, U.S. President Barack Obama designated September 2009 as National Ovarian Cancer Awareness Month. National Ovarian Cancer Awareness Month helps educate women and men about the importance…
- August 24th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
To Fight Cancer, Know The Enemy
An Op-Ed entitled “To Fight Cancer, Know the Enemy” was published in The New York Times on August 6, 2009. The author of the Op-Ed was James D. Watson, Ph.D. James Watson co-discovere…
- August 21st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
UA Research Team Designing Holographic Imaging System For Ovarian Cancer
University of Arizona researchers Jennifer Barton and Ray Kostuk have received a five-year, $2.4 million grant from the National Institutes of Health to build the instrument that they hope will one d…
- August 19th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
NCCN Updates Infection Guidelines To Include Information About H1N1 Virus (Swine Flu)
NCCN [National Comprehensive Cancer Network] recently updated the NCCN Clinical Practice Guidelines in Oncology™ for the Prevention and Treatment of Cancer-Related Infections to include information…
- August 14th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
The U.S. Food and Drug Administration (FDA) published two rules [on August 12, 2009] …that seek to clarify the methods available to seriously ill patients interested in gaining access to investi…
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Women Often Opt to Surgically Remove Their Breasts, Ovaries to Reduce Cancer Risk
Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers…
- August 11th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Young Early-Stage Ovarian Cancer Patients Can Preserve Fertility
A new study finds that young women with early-stage ovarian cancer can preserve future fertility by keeping at least one ovary or the uterus without increasing the risk of dying from the disease. The…
- August 10th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Novel Targeted Gene Therapies Use Diphtheria Toxin To Fight Ovarian Cancer; Future Clinical Trials Anticipated
Two separate research teams reported promising results last week based upon preclinical studies involving the use of diphtheria toxin to fight ovarian cancer. … A targeted gene therapy was…
- August 7th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Ovary Removal May Increase Lung Cancer Risk
Women who have premature menopause because of medical interventions are at an increased risk of developing lung cancer, according to a new study published in the International Journal of Cancer. The…
- August 3rd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Beyond BRCA1 & BRCA2: U.K. Researchers Identify Genetic Defect That Could Increase Risk of Ovarian Cancer Up To 40%
Scientists have located a region of DNA which – when altered – can increase the risk of ovarian cancer according to research published in Nature Genetics today. An international research group le…
- August 1st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
New Study Shows Four-Year Window for Early Detection of Ovarian Cancer
A new study by Howard Hughes Medical Institute researchers shows that most early stage ovarian tumors exist for years at a size that is a thousand times smaller than existing tests can detect reliably…
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Trojan Horse* For Ovarian Cancer–Nanoparticles Turn Immune System Soldiers Against Tumor Cells
In a feat of trickery, Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hard-to-treat tumor. U…
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
M.D. Anderson’s EphA2-Targeted Therapy Delivers Chemo Directly to Ovarian Cancer Cells
With a novel therapeutic delivery system, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center has successfully targeted a protein that is over-expressed in ovaria…
- July 28th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Vox Populi*: Libby, We’ll Be Missing You
Vox Populi: Libby, We’ll Be Missing You. Dear Libby, One year ago today, you left us after an extended battle with ovarian cancer. You are missed as a wife, a daughter, a sister, an aunt an…
- July 16th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
2009-2010 U.S. News & World Report Best U.S. Hospital Rankings
Today, U.S. News & World Report issued its 2009-2010 rankings of the best U.S. hospitals for adults. The University of Texas, M.D. Anderson Cancer Center is rated #1 in cancer treatment; Brigham a…
- June 18th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Feel The Vibe: SocialVibe.com Empowers Libby’s H*O*P*E* To Raise Money For Cancer Research
Today, Libby’s H*O*P*E*™ added a new widget to the homepage right sidebar. The widget, provided by SocialVibe.com, allows our sponsor, the TNT Network, to make donations to Stand Up To Cance…
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
2009 ASCO Annual Meeting Highlights: Ovarian Cancer & Select General Issues
The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Orlando, Florida from May 29 through June 2, 2009. We provide below select highlights from the 2009 ASCO Annual Meeti…
- June 11th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
One In Three Billion Found: Single Mutation In FOXL2 Gene May Cause Granulosa Cell Ovarian Cancer
“… Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a sin…
- June 5th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Gloria Johns Was Told “Ovarian Cancer Patients Don’t Live Long Enough … To Have Support Groups;” She Proved Otherwise
Every so often, you come across a story of hope, courage, and dogged perseverance that renews the spirit and lifts the soul. Gloria Johns’ story is a classic example. Gloria Johns is a 61 ye…
- June 3rd, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Gene Network Sciences, UConn To Work On Computer-Modeled Ovarian Cancer Treatments
Gene Network Sciences, Inc. (GNS) today announced that it has entered into a research collaboration with The University of Connecticut Health Center’s Carole and Ray Neag Comprehensive Cancer Ce…
- May 31st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Vox Populi*: A Daughter’s Thoughts On The 5th Anniversary of Her Mother’s Death From Ovarian Cancer
Vox Populi*: A Daughter’s Thoughts On the 5th Anniversary of Her Mother’s Death From Ovarian Cancer Five Years. by Kia, Good Enough Mama weblog, February 8, 2009 Dear Mom, Today marks t…
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Early Treatment of Recurrent Ovarian Cancer Based Upon Rising CA-125 Levels Does Not Increase Survival
“European researchers report [at the 2009 American Society of Clinical Oncology Annual Meeting being held in Orlando, Florida from May 29 through June 2nd] that starting treatment early for an o…
- May 29th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Stand Up To Cancer Funded Research Dream Team Takes Aim At Women’s Cancers
Stand Up To Cancer (SU2C), the Entertainment Industry Foundation’s charitable initiative supporting groundbreaking research aimed at getting new cancer treatments to patients in an accelerated t…
- May 24th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Genetic Testing For Hereditary Breast and Ovarian Cancers Greatly Underutilized By High-Risk Women
A women’s lifetime breast cancer risk is approximately 13 percent, and her ovarian cancer risk is less than 2 percent. But women with BRCA1 (BReast CAncer 1) or BRCA2 (BReast CAncer 2) gene mu…
- May 21st, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Researchers Are On The TRAIL To Killing Cancer With Genetically-Engineered Adult Stem Cells
“Researchers in London have demonstrated the ability of adult stem cells from bone marrow (mesenchymal stem cells, or MSCs) to deliver a cancer-killing protein to tumors. The genetically engin…
- May 18th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Mesothelin – A Potential New Target For Ovarian Cancer ImmunoTherapy
Researchers have generated altered immune cells that are able to shrink, and in some cases eradicate, large tumors in mice. The immune cells target mesothelin, a protein that is highly expressed, or t…
- May 17th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Symptoms Of Ovarian Cancer Remain Relatively Stabile Over Time As Reported By High Risk Women
Researchers from the Fred Hutchinson Cancer Research Center reported recently that symptoms of ovarian cancer tend to be relatively stable over time for women who are at increased risk of ovarian canc…
- May 16th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Ginger Quells Cancer Patients’ Chemotherapy-Related Nausea
“People with cancer can reduce post-chemotherapy nausea by 40 percent by using ginger supplements, along with standard anti-vomiting drugs, before undergoing treatment, according to scientists a…
- May 14th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
2009 ASCO Annual Meeting Abstracts Now Available Online
The 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) will be held in Orlando, Florida from May 29 through June 2, 2009. The ASCO Annual Meeting will be a forum for cutting-edge…
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Husband’s Love For Wife Inspires A 9,000 Mile Bike Trek To Raise Money For Ovarian Cancer Awareness & Cancer Prevention
On May 15, 2009, Craig Broeder Ph.D., FACSM, FNAASO will embark upon a 100-day bike trek that will take him to 32 U.S. cities as part of a 9,000 mile circumnavigation of the U.S. Since July 2008,…
- May 13th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
ACLU Challenges Patents On Genes Responsible For Hereditary Breast and Ovarian Cancers
“The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit … charging that patents on two human genes associated wit…
- May 12th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
UPCI Launches Clinical Trial for Patients with Hereditary Breast and Ovarian Cancers
“The University of Pittsburgh Cancer Institute (UPCI) will be the primary site for a clinical trial of ABT-888, a drug previously proven in combination treatments to improve chemotherapy’s…
- May 6th, 2009
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Women’s Gynecological Exams: Another Victim Of The Troubled Economy?
“… At Mother’s Day, a new survey from the National Ovarian Cancer Coalition (NOCC), www.ovarian.org, reveals some startling facts about women’s health: more than 52 percent of women ex…
-
hope4today has posted a new entry on: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)
Pattern of Genetic Faults Could Predict Whether An Ovarian Cancer Patient Will Respond to Common Chemo Drugs
“… A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK st…
